Identification of modulators of neurotransmitter activity of xanthurenic acid
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 17, 2006
Grant Date -
Aug 12, 2004
app pub date -
Jul 4, 2002
filing date -
Jul 5, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to methods and compositions for the selection and development of novel pharmacological agents or novel medicaments having properties or mechanisms of action which are original. The invention specifically describes the characterization and identification of the functional role of several constitutive elements of the central nervous system playing a role in the metabolism or transport of xanthurenic acid (XA) or involved in receiving and/or transducing the signal mediated by this substance. Said targets are new tools for the definition and selection of novel synthetic chemical substances, interfering with said targets and modulating the functions of XA in order to benefit from the pharmacological or medicamentous advantages thereof. The invention can be primarily used to treat neurological or mental pathologies or diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully